David Blaine Ridley : Citation Profile

Duke University (20% share)
Duke University (80% share)

7

H index

5

i10 index

140

Citations

RESEARCH PRODUCTION:

12

Articles

7

Papers

RESEARCH ACTIVITY:

   17 years (2006 - 2023). See details.
   Cites by year: 8
   Journals where David Blaine Ridley has often published
   Relations with other researchers
   Recent citing documents: 9.    Total self citations: 7 (4.76 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pri238
   Updated: 2025-12-20    RAS profile: 2024-01-05    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Lawler, Emily (2)

Liebman, Eli (2)

Dunn, Abe (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with David Blaine Ridley.

Is cited by:

Munoz-Garcia, Felix (14)

Espinola-Arredondo, Ana (13)

Turolla, Stéphane (6)

Bonein, Aurélie (6)

Dubois, Pierre (5)

Schuetz, Jenny (5)

Soetevent, Adriaan (4)

Kyle, Margaret (3)

Clemens, Jeffrey (3)

Heijnen, Pim (3)

Gottlieb, Joshua (3)

Cites to:

Duggan, Mark (8)

Ching, Andrew (6)

Hart, Oliver (4)

Shum, Matthew (4)

Salkever, David (4)

Lichtenberg, Frank (4)

Philipson, Tomas (4)

Newhouse, Joseph (4)

Kyle, Margaret (4)

Goldberg, Pinelopi (4)

Barwick, Panle (4)

Main data

Where David Blaine Ridley has published?

Journals with more than one article published# docs
International Journal of Industrial Organization3

Working Papers Series with more than one paper published# docs
NBER Working Papers / National Bureau of Economic Research, Inc3
Post-Print / HAL2

Recent works citing David Blaine Ridley (2025 and 2024)

YearTitle of citing document
2025Evaluation 2 of Pharmaceutical Pricing and R&D as a Global Public Good. (2025). . In: The Unjournal Evaluations. RePEc:bjn:evalua:e2pharmpricing.

Full description at Econpapers || Download paper

2025Global public goods, fiscal policy coordination, and welfare in the world economy. (2025). Agénor, Pierre-Richard ; Agnor, Pierre-Richard ; Pereira, Luiz A. In: European Economic Review. RePEc:eee:eecrev:v:172:y:2025:i:c:s0014292124002435.

Full description at Econpapers || Download paper

2025Marketing authorization and strategic patenting: Evidence from pharmaceuticals. (2025). Wang, Lucy Xiaolu ; Byrski, Dennis. In: Journal of Public Economics. RePEc:eee:pubeco:v:247:y:2025:i:c:s0047272725001136.

Full description at Econpapers || Download paper

2024Digitally accessible space: Discovery of the distinctive locational characteristics of restaurants with online reservation. (2024). Park, Chulwoong ; Kim, Youngchul. In: Technological Forecasting and Social Change. RePEc:eee:tefoso:v:209:y:2024:i:c:s0040162524005869.

Full description at Econpapers || Download paper

2024Strategic Merger Approvals Under Incomplete Information. (2024). Espinola-Arredondo, Ana ; Munoz-Garcia, Felix ; Kanjilal, Kiriti. In: Review of Industrial Organization. RePEc:kap:revind:v:65:y:2024:i:3:d:10.1007_s11151-024-09961-1.

Full description at Econpapers || Download paper

2025The second mover’s market research dilemma. (2025). Christen, Markus ; Soberman, David A. In: Journal of Marketing Analytics. RePEc:pal:jmarka:v:13:y:2025:i:2:d:10.1057_s41270-024-00320-3.

Full description at Econpapers || Download paper

2025Pharmaceutical Regulation and Incentives for Innovation in an International Perspective. (2025). Dubois, Pierre. In: TSE Working Papers. RePEc:tse:wpaper:131002.

Full description at Econpapers || Download paper

2024Auditing the prescription drug consumer price index in a changing marketplace. (2024). Frank, Richard G ; Berndt, Ernst R ; Hicks, Andrew L. In: Health Economics. RePEc:wly:hlthec:v:33:y:2024:i:8:p:1793-1810.

Full description at Econpapers || Download paper

2025Marketing Status and Brand‐Name Drug Prices: Evidence From Rx‐To‐OTC Switch. (2025). Wang, BO ; Lin, Lin. In: Health Economics. RePEc:wly:hlthec:v:34:y:2025:i:6:p:1064-1084.

Full description at Econpapers || Download paper

Works by David Blaine Ridley:

YearTitleTypeCited
2017The Role of Government Reimbursement in Drug Shortages In: American Economic Journal: Economic Policy.
[Full Text][Citation analysis]		article14
2012The Role of Government Reimbursement in Drug Shortages.(2012) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 14		paper
2008Herding versus Hotelling: Market Entry with Costly Information In: Journal of Economics & Management Strategy.
[Full Text][Citation analysis]		article28
2009Herding versus Hotelling: Market Entry with Costly Information.(2009) In: Levine's Working Paper Archive.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 28		paper
2013Innovation Incentives under Transferable Fast-Track Regulatory Review In: Journal of Industrial Economics.
[Full Text][Citation analysis]		article3
2017Strategic Interaction Among Governments in the Provision of a Global Public Good In: CEPR Discussion Papers.
[Full Text][Citation analysis]		paper8
2017Strategic interaction among governments in the provision of a global public good.(2017) In: Journal of Public Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 8		article
2017Strategic interaction among governments in the provision of a global public good.(2017) In: Post-Print.
[Citation analysis]
This paper has nother version. Agregated cites: 8		paper
2017Strategic interaction among governments in the provision of a global public good.(2017) In: Post-Print.
[Citation analysis]
This paper has nother version. Agregated cites: 8		paper
2009Distance decreases with differentiation: Strategic agglomeration by retailers In: International Journal of Industrial Organization.
[Full Text][Citation analysis]		article40
2013Pharmaceutical followers In: International Journal of Industrial Organization.
[Full Text][Citation analysis]		article19
2013Pharmaceutical Followers.(2013) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 19		paper
2017Regulation of price increases In: International Journal of Industrial Organization.
[Full Text][Citation analysis]		article1
2023Consequences of a shortage and rationing: Evidence from a pediatric vaccine In: Journal of Health Economics.
[Full Text][Citation analysis]		article0
2023Consequences of a Shortage and Rationing: Evidence from a Pediatric Vaccine.(2023) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0		paper
2006Impact of Medicaid Preferred Drug Lists on Therapeutic Adherence In: PharmacoEconomics.
[Full Text][Citation analysis]		article3
2020Does Medicare Reimbursement Drive Up Drug Launch Prices? In: The Review of Economics and Statistics.
[Full Text][Citation analysis]		article5
2015PAYMENTS, PROMOTION, AND THE PURPLE PILL In: Health Economics.
[Full Text][Citation analysis]		article7
2007Entry and competition in generic biologics In: Managerial and Decision Economics.
[Full Text][Citation analysis]		article12

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 20 2025. Contact: CitEc Team